| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/15/2001 | WO2001018214A1 Nucleic acids encoding ribonucleases and methods of making them |
| 03/15/2001 | WO2001018213A1 Chimeric thermostable dna polymerases |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018200A1 Tsg-like gene |
| 03/15/2001 | WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | WO2001018195A2 Luciferase expression cassettes and methods of use |
| 03/15/2001 | WO2001018184A1 Variant nucleoside-5'-phosphate producing enzyme |
| 03/15/2001 | WO2001018183A1 Methods and compositions for production of floral scent compounds |
| 03/15/2001 | WO2001018182A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 03/15/2001 | WO2001018179A1 Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018168A1 Device for introducing pores into biological materials |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017572A1 Materials for culturing cardiovascular tissues and method of tissute regeneration |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000070037A3 Directed evolution of microorganisms |
| 03/15/2001 | WO2000068375A3 Modified pm and pu promoters of tol plasmids |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066711A3 Streptococcus gordonii strains resistant to fluorodeoxyuridine |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000065061A3 Nucleic acid sequences from candida yeasts which code cytochrome b5 polypeptides |
| 03/15/2001 | WO2000029603A8 Low cost manufacture of oligosaccharides |
| 03/15/2001 | WO1999054454A9 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943587A1 Neue für das dapF-Gen codierende Nukleotidsequenzen New coding for the dapF gene nucleotide sequences |
| 03/15/2001 | DE19941768A1 New Schizosaccharomyces pombe mutants with defective potassium uptake useful for expressing human eag related gene in screening assays for potassium ion channel modulators |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE10044468A1 New nucleic acid encoding delta-6-desaturase, useful for producing ciliates and plants that overproduce unsaturated fatty acids, derived from Tetrahymena |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2403330A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384496A1 Luciferase expression cassettes and methods of use |
| 03/15/2001 | CA2384123A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384000A1 Regulatory sequences and expression systems functioning in filamentous fungi |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382434A1 Device for introducing pores into biological materials |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2318507A1 Novel nucleotide sequences coding for the pgi gene |
| 03/14/2001 | EP1083233A1 Production of natural flavors by laccase catalysis |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083225A1 Method for the fermentative production of D-pantothenic acid using coryneform bacteria |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1082457A2 Nucleic acid encoding rate agouti related protein |
| 03/14/2001 | EP1082448A1 Improved process for alcoholic fermentation |
| 03/14/2001 | EP1082441A1 Mycobacterial n-acetyltransferases |
| 03/14/2001 | EP1082440A1 LIPOPOLYSACCHARIDE $g(a)-2,3 SIALYLTRANSFERASE OF $i(CAMPYLOBACTER JEJUNI) AND ITS USES |
| 03/14/2001 | EP1082439A2 Recombinant narbonolide polyketide synthase |
| 03/14/2001 | EP1082438A2 Genetic method for producing riboflavin |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082434A1 NOVEL INSECTICIDAL TOXINS FROM $i(XENORHABDUS NEMATOPHILUS) AND NUCLEIC ACID SEQUENCES CODING THEREFOR |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082431A2 Protease inhibitor peptides |
| 03/14/2001 | EP1082430A1 Kunitz domain polypeptide and materials and methods for making it |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082423A1 Cyclin e2 genes and proteins |
| 03/14/2001 | EP1082420A2 Human nucleic acid sequences from normal pancreas tissue |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082404A2 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082021A1 Process for the manufacture of probiotic cheese |
| 03/14/2001 | CN1287107A Antibiotic fertilizer with humic acid |
| 03/14/2001 | CN1286935A Aweto soy sauce and its production process |
| 03/14/2001 | CN1063225C Microbe, microbe cotton cake detoxic agent and its producing process |
| 03/14/2001 | CN1063051C Bifidobacterium compound live vaccine preparation |
| 03/14/2001 | CN1063050C Deep culture solution of Chinese caterpillar fungus |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6201005 Method for inhibiting lymphokine production |
| 03/13/2001 | US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy |
| 03/13/2001 | US6200813 Altering substrate specificity of polyketide synthase by isolating genomic dna fragments which encode acyltransferase domain, transforming cell having one fragment with other fragment for homologous recombination; antibiotics |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |